| Phase 3 |
| NCT06713837 |
IMPACT-AML: A Randomized Pragmatic Clinical Trial for Relapsed or Refractory Acute… |
Acute Myeloid Leukemia |
Recruiting |
| Phase 2 |
| NCT06045260 |
"Receptor Radionuclide Therapy With 177Lu-DOTATOC |
Neuroendocrine Tumors |
Recruiting |
| NCT02919644 |
Vaccination with Autologous Dendritic Cells Loaded with Autologous Tumour Homogenate… |
Stage IV Colorectal Cancer |
Recruiting |
| NCT04166006 |
A Phase II Study on Adjuvant Vaccination with Dendritic Cells Loaded with Autologous… |
Head Neck Tumors |
Recruiting |
| NCT05772390 |
Partial Breast Re-irradiation in Women in Women with Locally Recurrent Breast Cancer… |
Breast Cancer |
Recruiting |
| NCT06522919 |
Sequential Immunochemotherapy Treatment with Pembrolizumab Plus Dendritic Cell (DC)… |
Colorectal Cancer Metastatic |
Recruiting |
| NCT05623319 |
Pembrolizumab and Olaparib Treatment of Extensive Small Cell Lung Cancer (ES-SCLC) |
SCLC,Extensive Stage |
Recruiting |
| NCT04523688 |
Vaccination With Autologous Dendritic Cells Loaded With Autologous Tumour Homogenate in… |
Glioblastoma |
Recruiting |
| NCT05893381 |
Lu-PSMA and Stereotactic Radiotherapy Versus Radiotherapy Alone for Prostate Cancer (LUST) |
Prostate Cancer |
Recruiting |
| NCT03454763 |
Optimizing the Interval Between Cycles of PRRT with 177lu-dotatate in Sstr2 Positive… |
Neuroendocrine Tumors |
Active, Not Recruiting |
| NCT03230734 |
Sequencing of Radium-223 and Docetaxel in Symptomatic Bone-only Metastatic… |
Metastatic Castration-resistant Prostate Cancer |
Active, Not Recruiting |
| NCT05867615 |
Radiometabolic Therapy With 177Lu PSMA in PSMA PET/CT Positive Advanced/Metastatic… |
Cancer |
Active, Not Recruiting |
| Phase 1 |
| NCT03546426 |
Pembrolizumab Plus Autologous Dendritic Cell Vaccine in Patients with PD-L1 Negative… |
Mesothelioma, Malignant |
Active, Not Recruiting |
| Not specified |
| NCT06367491 |
National Database of Bone Metastases |
Bone Metastases |
Recruiting |
| NCT04842916 |
InteGRAtive Analysis of TuMor, Microenvironment, ImmunitY and Patient Expectation for… |
Gastric Cancer |
Recruiting |
| NCT04590560 |
What is the Best Interval to Screen Women 45-49 and 70-74 for Breast Cancer? |
Breast Cancer |
Recruiting |
| NCT06895291 |
Whole Body MRI in Oncology |
Lymphoma |
Recruiting |
| NCT06919393 |
"Triple Negative" Adult B-cell Acute Lymphoblastic Leukemia - TRINEG-ALL |
Leukemia, Lymphoblastic |
Recruiting |
| NCT04300101 |
Mixed Molecular Clinical Index (MMCI) in Diffuse Large B-cell Lymphoma (DLBCL) |
Diffuse Large B Cell Lymphoma |
Recruiting |
| NCT06459024 |
Master Framework For Relapse or Refractory Acute Myeloid Leukemia |
Acute Myeloid Leukemia, in Relapse |
Recruiting |
| NCT03789981 |
Exploring Disease Immunogenicity and the Immunological Effects of Hypomethylating Agents… |
Acute Myeloid Leukemia |
Active, Not Recruiting |
| NCT03269227 |
Accelerated Hypofractionated Radiotherapy in the Treatment of Malignant Pleural… |
Malignant Pleural Mesothelioma |
Active, Not Recruiting |